Target Details
| UniProt AC | Q09472 |
|---|---|
| Gene Symbol | EP300 |
| Protein Name | Histone acetyltransferase p300 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00439 (Bromodomain) PF09030 (Creb_binding) PF08214 (HAT_KAT11) PF02172 (KIX) PF23570 (PHD_P300) PF06001 (RING_CBP-p300) PF02135 (zf-TAZ) PF00569 (ZZ) |
Summary
- Multi-target molecules 320
- Clinical molecules 0
- Avg pChEMBL 7.05
KEGG Pathways (29)
- Adherens junction
- Cadherin signaling
- Cell cycle
- FoxO signaling pathway
- Glucagon signaling pathway
- Growth hormone synthesis, secretion and action
- HIF-1 signaling pathway
- Hepatitis B
- Human T-cell leukemia virus 1 infection
- Human papillomavirus infection
- Huntington disease
- Influenza A
- JAK-STAT signaling pathway
- Kaposi sarcoma-associated herpesvirus infection
- Long-term potentiation
- Melanogenesis
- MicroRNAs in cancer
- Notch signaling pathway
- Pathways in cancer
- Polycomb repressive complex
- Prostate cancer
- Renal cell carcinoma
- TGF-beta signaling pathway
- Thyroid hormone signaling pathway
- Tuberculosis
- Viral carcinogenesis
- Viral life cycle - HIV-1
- Wnt signaling pathway
- cAMP signaling pathway
Associated Diseases (5)
Active Molecules (320)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
MUJXZEDIWKGKQD
|
9.9 | Kd | 2 | — | |
AXUWOPMZIMEOGX
|
9.7 | IC50 | 2 | — | |
BEGITSSNCCVVNP
|
9.7 | IC50 | 2 | — | |
OJCJBSVDYBMCLG
|
9.4 | IC50 | 2 | — | |
VDSIQACOIMEICT
|
9.4 | IC50 | 2 | — | |
BKCHTXXAFMJELI
|
9.3 | IC50 | 2 | — | |
YXSUJYIAFJZLAJ
|
9.3 | IC50 | 2 | — | |
GNHYVESLYMWXEL
|
9.2 | IC50 | 2 | — | |
MRECOMFGRKBNFR
|
9.2 | IC50 | 2 | — | |
NHHZZRLTZUGGEB
|
9.2 | IC50 | 2 | — | |
MWZMDGHSCHBFBT
|
9.1 | IC50 | 2 | — | |
GMWJOJAVQDJWLP
|
9.0 | IC50 | 2 | — | |
QULMQLITKMCMAK
|
9.0 | IC50 | 2 | — | |
SKDNDJWEBPQKCS
|
8.9 | Kd | 3 | — | |
GGXPWHYWZIJKLJ
|
8.8 | IC50 | 2 | — | |
AMMLBLXPKVTDJJ
|
8.7 | IC50 | 2 | — | |
AOJDZTGIEQDZQT
|
8.7 | IC50 | 2 | — | |
ASOVGHSPVKESKS
|
8.7 | IC50 | 2 | — | |
QIKLULUJXFBMBV
|
8.7 | IC50 | 2 | — | |
OLGHKQPFBIYQAO
|
8.7 | IC50 | 2 | — | |
HPCJDXNTSDAQDE
|
8.5 | IC50 | 2 | — | |
QOWVZONOCYVEKT
|
8.5 | IC50 | 2 | — | |
OISTZKLYQBJTIE
|
8.4 | IC50 | 2 | — | |
GHSPKSUJZGNCRJ
|
8.4 | IC50 | 2 | — | |
ZLEMLLJTYHFBLY
|
8.4 | IC50 | 2 | — | |
ATLJVYAAMGQNOV
|
8.4 | IC50 | 2 | — | |
MSDYJZMQGKWYMG
|
8.4 | IC50 | 2 | — | |
LRZCYVBEUGFNBN
|
8.4 | IC50 | 2 | — | |
SKDNDJWEBPQKCS
|
8.3 | IC50 | 5 | — | |
ANNRMMKYSMNVEX
|
8.3 | IC50 | 2 | — | |
NXUZCURQFURQPB
|
8.3 | IC50 | 2 | — | |
VDINOEOOUILKFN
|
8.3 | IC50 | 2 | — | |
LQHXVSXJYDRTMV
|
8.2 | IC50 | 2 | — | |
NHCPFAJXHXYDCP
|
8.2 | IC50 | 2 | — | |
QKXMJDAHBMDGDO
|
8.2 | IC50 | 2 | — | |
REJIMCLBQYAVMK
|
8.2 | IC50 | 2 | — | |
NECOUNXTTAVFPN
|
8.2 | IC50 | 2 | — | |
VLSSRXAUNKQKKE
|
8.2 | IC50 | 2 | — | |
JPEYACZELJYCMI
|
8.1 | IC50 | 2 | — | |
QFOWHCHCRRILAW
|
8.1 | IC50 | 2 | — | |
QDOIWXLZWGTZOU
|
8.1 | IC50 | 2 | — | |
RHYAIWXUDDAZRD
|
8.1 | IC50 | 2 | — | |
ZWZNTJUYYCDESL
|
8.1 | IC50 | 2 | — | |
JDYFUWQEZLNYFW
|
8.0 | IC50 | 2 | — | |
OJALLZBPDOMARU
|
8.0 | IC50 | 2 | — | |
SEDFZSHSBUXKAC
|
8.0 | IC50 | 2 | — | |
DBCMAPQJHUHFJH
|
8.0 | IC50 | 2 | — | |
VRVJKILQRBSEAG
|
8.0 | IC50 | 2 | — | |
QHEXIHFMBFZCSJ
|
8.0 | IC50 | 2 | — | |
RYCIBPVLRWPLSI
|
8.0 | IC50 | 2 | — |